![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Hoffmann, V. S.; Baccarani, M.; Hasford, Joerg; Lindörfer, Doris; Burgstaller, S.; Sertic, D.; Costeas, P.; Mayer, J.; Indrak, K.; Everaus, H.; Koskenvesa, P.; Guilhot, J.; Schubert-Fritschle, Gabriele; Castagnetti, F.; Di Raimondo, F.; Lejniece, S.; Griskevicius, L.; Thielen, N.; Sacha, T.; Hellmann, A.; Turkina, A. G.; Zaritskey, A.; Bogdanovic, A.; Sninska, Z.; Zupan, I.; Steegmann, J. L.; Simonsson, B.; Clark, R. E.; Covelli, A.; Guidi, G. und Hehlmann, R.
(2015):
The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries.
In: Leukemia, Bd. 29, Nr. 6: S. 1336-1343
Hoffmann, V. S.; Baccarani, M.; Lindörfer, Doris; Castagnetti, F.; Turkina, A.; Zaritsky, A.; Hellmann, A.; Prejzner, W.; Steegmann, J. L.; Mayer, J.; Indrak, K.; Colita, A.; Rosti, G. und Pfirrmann, Markus
(2013):
The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib.
In: Leukemia, Bd. 27, Nr. 10: S. 2016-2022
Hasford, Joerg; Pfirrmann, Markus; Shepherd, P.; Guilhot, J.; Hehlmann, R.; Mahon, F. X.; Kluin-Nelemans, H. C.; Ohnishi, K.; Steegmann, J. L. und Thaler, J.
(2005):
The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha.
In: Haematologica, Bd. 90, Nr. 3: S. 335-340
Hasford, Joerg; Pfirrmann, Markus; Hehlmann, R.; Baccarani, M.; Guilhot, F.; Mahon, F. X.; Kluin-Nelemans, H. C.; Ohnishi, K.; Thaler, J. und Steegmann, J. L.
(2003):
Prognosis and prognostic factors for patients with chronic myeloid leukemia: nontransplant therapy.
In: Seminars in Hematology, Bd. 40, Nr. 1: S. 4-12
Hasford, Joerg; Pfirrmann, Markus; Hehlmann, R.; Allan, N. C.; Baccarani, M.; Kluin-Nelemans, J. C.; Alimena, G.; Steegmann, J. L. und Ansari, H.
(3. Juni 1998):
A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.
In: Journal of the National Cancer Institute, Bd. 90, Nr. 11: S. 850-859